FOXN3 and lung carcinoma: A meta-analysis of the FOXN3 gene (using the oncomine database) demonstrated that among 15 different malignancies (including liver cancer, lung cancer, colon cancer, prostate cancer, laryngeal cancer, glioblastoma multiform, and lymphoma) there was a very marked down-regulation of the FOXN3 gene.